The Mens Eating and Living research led by co-investigators James Mohler.

Mohler.. Clinical trial to assess impact of nutritional change in men with prostate cancer Two researchers from Roswell Park Malignancy Institute have opened a clinical trial which will assess the influence of dietary modification to control prostate cancer. The Men’s Eating and Living research led by co-investigators James Mohler, MD, and James Marshall, PhD, is both the first to assess the effects of radical nutritional intervention on men with prostate cancer and the just current scientific investigation involving men positioned on active surveillance instead of active treatment for low-risk prostate cancer tumor.The CytoPulse instruments involved consist of DermaVax, OncoVet, Hybrimune, Cyto-LVT-S and Cyto-LVT-P. ‘We are delighted to work with Harvard Apparatus on the distribution of this very effective technology’, declared Dirk Pollet, Chief Business Officer for Cellectis. ‘This deal provides Harvard Apparatus with an excellent new products, while generating a robust revenue stream for Cellectis. In addition, it allows the technology to be made available to the research community to explore its potential.’ Chane Graziano, CEO of Harvard Bioscience, commented, ‘This license significantly expands the cell biology study product line provided by Harvard Apparatus beneath the Warner Instruments and BTX brands.’..